Recent News

• 08.19.2025 - Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer
• 08.19.2025 - Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer
• 08.19.2025 - Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer
• 08.11.2025 - Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
• 08.11.2025 - Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
• 08.11.2025 - Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
• 08.07.2025 - Second Quarter 2025 Financial Results
• 08.07.2025 - Second Quarter 2025 Financial Results
• 08.07.2025 - Second Quarter 2025 Financial Results
• 08.07.2025 - Viatris Reports Second Quarter 2025 Results and Reiterates 2025 Financial Guidance

Recent Filings

• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - 3 Initial statement of beneficial ownership of securities
• 08.11.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 8-K Current report
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors